Bilateral Conjunctival Lesions in Melkersson-Rosenthal Syndrome
October 2001
in “
British Journal of Ophthalmology
”
TLDR Intralesional cidofovir may be a viable treatment for conjunctival lesions in Melkersson-Rosenthal syndrome without systemic toxicity.
The document reported on a 64-year-old man with Melkersson-Rosenthal syndrome (MRS), a rare granulomatous disease characterized by recurrent facial edema, peripheral facial palsy, and a fissured tongue. The patient exhibited chronic bilateral conjunctival lesions, a symptom not previously associated with MRS. This case highlighted a potential new manifestation of the syndrome, expanding the understanding of its clinical presentation.
